celastrol has been researched along with Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, J; Ding, Y; Jiang, Y; Shao, Y; Si, L; Wang, M; Wang, S; Wei, K; Zhao, X | 1 |
| Anamalai, M; Deshmukh, S; Kaushal, S; Mishra, R; Patel, J; Sharma, S; Simpson, D; Singh, IS; Walker, BL; Zampino, M | 1 |
2 other study(ies) available for celastrol and Cardiomyopathies
| Article | Year |
|---|---|
Celastrol confers ferroptosis resistance via AKT/GSK3β signaling in high-fat diet-induced cardiac injury.
Topics: Animals; Cardiomyopathies; Diet, High-Fat; Ferroptosis; Glycogen Synthase Kinase 3 beta; Heart Injuries; Mice; Obesity; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2023 |
Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death.
Topics: Animals; Apoptosis; Cardiomyopathies; Cell Line, Tumor; Cell Survival; Disease Models, Animal; DNA-Binding Proteins; Doxorubicin; GATA4 Transcription Factor; Gene Expression; Heat Shock Transcription Factors; Heat-Shock Proteins; Humans; Interleukin-1beta; Interleukin-6; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Pentacyclic Triterpenes; Thioacetamide; Transcription Factors; Triterpenes; Tumor Necrosis Factor-alpha | 2015 |